DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,151,052 | +5.1% | 20,762 | +1.7% | 0.68% | +9.6% |
| Q2 2023 | $4,901,280 | -4.8% | 20,422 | 0.0% | 0.62% | -7.4% |
| Q1 2023 | $5,147,161 | -4.9% | 20,422 | +0.1% | 0.67% | -8.6% |
| Q4 2022 | $5,413,772 | +8.1% | 20,397 | +5.2% | 0.73% | -4.7% |
| Q3 2022 | $5,010,000 | +2.4% | 19,397 | +0.5% | 0.76% | +2.5% |
| Q2 2022 | $4,894,000 | -13.5% | 19,305 | +0.0% | 0.75% | +6.1% |
| Q1 2022 | $5,660,000 | -11.1% | 19,297 | -0.3% | 0.70% | -5.3% |
| Q4 2021 | $6,365,000 | +8.1% | 19,347 | 0.0% | 0.74% | -6.4% |
| Q3 2021 | $5,890,000 | +12.1% | 19,347 | -1.2% | 0.79% | +17.0% |
| Q2 2021 | $5,256,000 | +19.2% | 19,587 | 0.0% | 0.68% | +12.4% |
| Q1 2021 | $4,409,000 | +1.3% | 19,587 | 0.0% | 0.60% | -5.8% |
| Q4 2020 | $4,351,000 | +3.2% | 19,587 | 0.0% | 0.64% | -7.4% |
| Q3 2020 | $4,218,000 | +21.8% | 19,587 | 0.0% | 0.69% | +14.8% |
| Q2 2020 | $3,464,000 | +20.1% | 19,587 | -6.0% | 0.60% | +6.0% |
| Q1 2020 | $2,884,000 | -10.5% | 20,837 | -0.7% | 0.57% | +11.6% |
| Q4 2019 | $3,221,000 | +5.1% | 20,987 | -1.1% | 0.51% | -6.4% |
| Q3 2019 | $3,064,000 | +0.1% | 21,212 | -0.9% | 0.54% | +2.8% |
| Q2 2019 | $3,060,000 | +6.8% | 21,412 | -1.4% | 0.53% | +3.7% |
| Q1 2019 | $2,866,000 | +27.7% | 21,712 | -0.2% | 0.51% | +13.8% |
| Q4 2018 | $2,244,000 | -4.1% | 21,762 | +1.0% | 0.45% | +7.7% |
| Q3 2018 | $2,341,000 | +10.1% | 21,540 | 0.0% | 0.42% | +2.7% |
| Q2 2018 | $2,126,000 | +1.3% | 21,540 | +0.5% | 0.40% | -2.4% |
| Q1 2018 | $2,099,000 | +5.6% | 21,440 | +0.1% | 0.42% | +7.5% |
| Q4 2017 | $1,987,000 | +9.8% | 21,410 | +1.5% | 0.39% | +4.6% |
| Q3 2017 | $1,809,000 | +2.1% | 21,090 | +0.5% | 0.37% | -3.9% |
| Q2 2017 | $1,771,000 | -1.3% | 20,990 | 0.0% | 0.38% | -2.0% |
| Q1 2017 | $1,795,000 | +26.1% | 20,990 | +14.7% | 0.39% | +22.5% |
| Q4 2016 | $1,424,000 | +5.6% | 18,300 | +6.4% | 0.32% | +0.9% |
| Q3 2016 | $1,348,000 | -19.9% | 17,200 | +3.3% | 0.32% | -22.3% |
| Q2 2016 | $1,682,000 | +2.8% | 16,650 | -3.5% | 0.41% | +1.0% |
| Q1 2016 | $1,636,000 | +1.8% | 17,250 | -0.3% | 0.40% | -5.6% |
| Q4 2015 | $1,607,000 | +10.0% | 17,300 | +0.9% | 0.43% | +6.5% |
| Q3 2015 | $1,461,000 | +8.1% | 17,150 | +8.5% | 0.40% | +16.5% |
| Q2 2015 | $1,352,000 | +0.8% | 15,800 | 0.0% | 0.34% | +2.7% |
| Q1 2015 | $1,341,000 | -2.2% | 15,800 | -1.2% | 0.34% | +7.7% |
| Q4 2014 | $1,371,000 | +12.7% | 16,000 | 0.0% | 0.31% | +6.1% |
| Q3 2014 | $1,216,000 | -3.5% | 16,000 | 0.0% | 0.29% | -1.3% |
| Q2 2014 | $1,260,000 | +5.0% | 16,000 | 0.0% | 0.30% | -4.2% |
| Q1 2014 | $1,200,000 | -5.8% | 16,000 | -3.0% | 0.31% | -7.4% |
| Q4 2013 | $1,274,000 | +13.8% | 16,500 | +2.2% | 0.34% | +5.3% |
| Q3 2013 | $1,120,000 | +9.6% | 16,150 | 0.0% | 0.32% | +4.6% |
| Q2 2013 | $1,022,000 | – | 16,150 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |